Fenoldopam

This classification denotes a dopamine agonist with the molecular formula C16H16ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier INU8H2KAWG, chemically known as 1h-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)- but generally known as fenoldopam, which bears US NIH Compound Identifier 3341. European Medicines Agency schedules Fenoldopam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07577MIG. The term FENOLDOPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules fenoldopam in its Anatomical Therapeutic Chemical (ATC) Classification. FENOLDOPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenoldopam under HS 29339930 and SITC 51577. As of Q4 2014, FENOLDOPAM remains the US FDA Preferred Term for this commodity. Fenoldopam bears US NLM identifiers UMLS ID C0060180 and NCI Concept Code C61759. SMILES: CLC1C2C(C(CNCC2)C2CCC(O)CC2)CC(O)C1O.